[Tissue-type plasminogen activator and pro-urokinase--new fibrinolytic agents in the treatment of myocardial infarction].
In the light of a survey of the pertinent literature the results of tissue plasminogen activator and pro-urokinase++ use in the thrombolytic treatment of acute myocardial infarction are discussed.
Czyrski
J
J
D004341:Drug Evaluation; D005343:Fibrinolytic Agents; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D010960:Plasminogen Activators / Q000627:therapeutic use*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator
Tkankowy aktywator plazminogenu i prourokinaza--nowe środki fibrynolityczne w leczeniu zawału serca.